Baseline ECG Assessment Before Starting Clozapine
Before initiating clozapine, obtain a baseline 12-lead ECG to assess for QT interval prolongation, pre-existing cardiac abnormalities, and conduction defects that could increase risk of fatal cardiac complications. 1
What to Look For on the Baseline ECG
Critical Parameters to Assess:
QTc interval: Measure the corrected QT interval to identify baseline prolongation. Clozapine can cause dose-dependent QTc prolongation 2, and pathologic prolongation (though rare) can be fatal 1. Patients with pre-existing QT prolongation are at higher risk for dangerous arrhythmias.
Conduction abnormalities: Look for bundle branch blocks, AV blocks, or other conduction delays that may worsen with clozapine's anticholinergic and cardiac effects.
Signs of structural heart disease: ST-segment changes, T-wave abnormalities, or pathologic Q waves may indicate underlying cardiomyopathy or ischemic disease. This is particularly important since clozapine carries a boxed warning for myocarditis and cardiomyopathy 1.
Rhythm abnormalities: Identify baseline arrhythmias, particularly atrial fibrillation or frequent ectopy, which may be exacerbated by clozapine-induced tachycardia.
Clinical Context and Risk Stratification
The FDA label emphasizes that myocarditis and cardiomyopathy can be fatal 1. A baseline ECG serves multiple purposes:
Documents pre-existing abnormalities: Approximately 13.6% of patients on other antipsychotics have baseline ECG abnormalities, which increases to 31.1% after clozapine initiation 2. Having baseline documentation allows you to distinguish pre-existing from clozapine-induced changes.
Identifies high-risk patients: Older patients and those with abnormal baseline ECGs are at increased risk for developing new ECG abnormalities 2. Consider cardiology consultation before initiating clozapine if significant cardiac disease or risk factors are present 3.
Establishes monitoring parameters: Most new ECG abnormalities occur during the initial treatment phase 2, making baseline comparison essential for detecting early cardiac complications.
Additional Baseline Cardiac Considerations
While the ECG is the primary screening tool, consider:
Echocardiography: Not routinely required for all patients, but should be obtained as part of cardiac consultation if patients have known cardiac disease or significant risk factors 3, 4. The 2026 Lancet Psychiatry guidelines recommend echocardiograms only if clinically indicated, not routinely 5.
Cardiac biomarkers: Some experts recommend baseline troponin and C-reactive protein 3, 6, though this is controversial and not universally mandated. These are more useful for monitoring during titration if myocarditis is suspected.
Common Pitfalls to Avoid
Don't skip the baseline ECG: Even in young, healthy patients, minor abnormalities can be overlooked on standard assessment 7. The ECG provides objective documentation that becomes critical if cardiac complications develop.
Don't ignore minor abnormalities: While most clozapine-induced ECG changes are benign 2, they require monitoring. Document all findings clearly for comparison during treatment.
Consider the full cardiac picture: The ECG is one component. Patients with pre-existing structural heart disease (like hypertrophic cardiomyopathy) can be treated with clozapine but require intensive monitoring with cardiology involvement 4.
Follow-Up ECG Monitoring
After baseline assessment, the 2026 consensus guidelines suggest considering annual ECGs, though this did not reach the 75% consensus threshold for a firm recommendation 5. More importantly, obtain an ECG immediately if any cardiac symptoms develop (chest pain, dyspnea, palpitations, syncope) as these may indicate myocarditis or cardiomyopathy requiring immediate clozapine discontinuation and cardiac evaluation 1.